Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...

Hyperfine, Inc. announced results from a large data set from an investigator-initiated study evaluating stroke detection with t ...

In a retrospective cohort study examining patterns of peripheral artery disease (PAD) diagnosis in United States primary care s ...

Penumbra announced the launch of the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT) system for the ...

The American Stroke Association (ASA) announced the publication of the 2026 guideline for the early management of patients with ...

Boston Scientific announced it has received CE Mark approval for the company’s Embold detachable coil system, which is a ...

CVRx, Inc. a developer of neuromodulation solutions for patients with cardiovascular diseases, announced initiation of the ...

Boston Scientific has initiated the limited market release of the Seismiq intravascular lithotripsy (IVL) system, marking the c ...

Kaneka Medical America LLC, a subsidiary company of Kaneka Corporation, announced the United States launch of Enlight Medical L ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

CereVasc, Inc. announced the completion of enrollment in its ETCHES 1 study of the company’s eShunt system for the treatm ...

Cathpax, a Nantes, France-based spin-off of the Lemer Pax group, announced the results of the NOVARAD clinical study evaluating ...